Psychiatrists’ Use of Biomarkers Could Open a New Window Into Mental Health Diagnoses
The world’s largest professional psychiatry organization is preparing for the day when biological indicators can help diagnose and treat mental illness.
Jamie Ducharme
Showing 1 - 2 of 2
-
-
As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off
Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether — and how — to taper patients off expensive GLP-1 drugs.
Sign Up For Our Newsletter
Stay informed by signing up for the Morning Briefing and other emails: